US Archives - Page 52 of 157 - European Medical Journal

Landmark Trial Spurs New Anal Cancer Screening Guidelines in HIV

Anal cancer screening in people with HIV (PWH) is entering a new era, following major advances in evidence and recent guideline updates that aim to reduce cancer burden in this high-risk group.

Psoriasis in Cancer: New Guidance Emerges

Immune checkpoint inhibitors (ICIs) have transformed cancer care but can trigger immune-related adverse events such as psoriasis, complicating treatment decisions.

Type 2 Inflammation in Pediatric Diseases

Uncover how multiple pediatric atopic diseases have a shared Type 2 inflammatory profile…

How Long-Term Care Homes Monitor HAIs and Resistance

A national survey of Canadian long-term care homes found that most facilities are actively monitoring healthcare-associated infections (HAIs), antimicrobial-resistant organisms (AROs), and antibiotic use, though the consistency and scope of these efforts vary.

GLP-1 Drugs Linked to Lower Dementia and Stroke Risk

GLP-1 receptor agonists like semaglutide and tirzepatide are linked to significantly lower risks of dementia, ischemic stroke, and all-cause mortality in adults with type 2 diabetes and obesity, according to a large US cohort study.

Dual Vaccine Shows Strong Immune Response in Adults Over 50

A new multicomponent vaccine targeting both seasonal influenza and SARS-CoV-2 has demonstrated noninferior immunogenicity and acceptable safety in adults aged 50 years and older, according to results from a Phase III randomized trial.

New Imaging Index Forecasts Lymphoma Progression

A novel deep learning approach to body composition analysis may offer a cost-effective and clinically relevant method to predict treatment outcomes in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to findings from the LOTIS-2 trial.

How Menopause Alters Systemic Sclerosis Outcomes

Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.

More Infants Treated for Hemangiomas Post-Beta-Blocker Era

The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.

Lack of Rigorous Clinical Data Risks Efficacy Decline in Influenza Vaccines

High-quality clinical data is essential to maintaining trust in influenza vaccination programs, especially as the global death toll from seasonal flu approaches 700,000 annually, disproportionately affecting older adults.